Cat.No：GM-79650AB
Product：Anti-RSV hIgG1 Antibody (palivizumab)
Cat.No：GM-79650AB
Product：Anti-RSV hIgG1 Antibody (palivizumab)
GM-79650AB-10 10 μg
GM-79650AB-100 100 μg
GM-79650AB-1000 1mg
Species Reactivity Human;
Clone palivizumab
Source/Isotype Monoclonal human IgG1, κ
Application /
Specificity Detects RSV
Gene RSV
Other Names MEDI 493
Gene ID 1489856
Background Respiratory Syncytial Virus (RSV) is a virus that primarily causes respiratory infections in infants, young children, and the elderly. RSV infections typically result in mild cold-like symptoms, but in high-risk groups, such as premature infants, immunocompromised individuals, and older adults, it can lead to severe lower respiratory tract diseases, including bronchiolitis and pneumonia.Palivizumab is a humanized monoclonal antibody that is primarily used to prevent severe respiratory infections caused by respiratory syncytial virus (RSV) , particularly in high-risk infants and young children. RSV is a common virus that usually causes mild to moderate respiratory infections, but in some high-risk children (such as premature infants, heart and lung disease, or children with weakened immune systems) , rSV infection may lead to severe pneumonia and hospitalization.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Cat.No：GM-79650AB
Product：Anti-RSV hIgG1 Antibody (palivizumab)
GM-79650AB-10 10 μg
GM-79650AB-100 100 μg
GM-79650AB-1000 1mg
Species Reactivity Human;
Clone palivizumab
Source/Isotype Monoclonal human IgG1, κ
Application /
Specificity Detects RSV
Gene RSV
Other Names MEDI 493
Gene ID 1489856
Background Respiratory Syncytial Virus (RSV) is a virus that primarily causes respiratory infections in infants, young children, and the elderly. RSV infections typically result in mild cold-like symptoms, but in high-risk groups, such as premature infants, immunocompromised individuals, and older adults, it can lead to severe lower respiratory tract diseases, including bronchiolitis and pneumonia.Palivizumab is a humanized monoclonal antibody that is primarily used to prevent severe respiratory infections caused by respiratory syncytial virus (RSV) , particularly in high-risk infants and young children. RSV is a common virus that usually causes mild to moderate respiratory infections, but in some high-risk children (such as premature infants, heart and lung disease, or children with weakened immune systems) , rSV infection may lead to severe pneumonia and hospitalization.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
